6-isopropyl-2-methyl-2,3-dihydro-1H-inden-1-one | 343945-54-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 6-isopropyl-2-methyl-2,3-dihydro-1H-inden-1-one
• 英文别名: 6-Isopropyl-2-methylindan-1-one；2-methyl-6-propan-2-yl-2,3-dihydroinden-1-one
• CAS: 343945-54-0
• 化学式: C₁₃H₁₆O
• 分子量: 188.269
• InChiKey: WQMYPDSAFDCWDP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  6-isopropyl-2-methyl-2,3-dihydro-1H-inden-1-one 在 硫酸 、 溶剂黄146 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 8.5h， 生成 ethyl 2-(5-isopropyl-2-methyl-1H-inden-3-yl)acetate
  参考文献：
  名称：

  Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation

  摘要：

  RXR alpha represents an intriguing and unique target for pharmacologic interventions. We recently showed that Sulindac and a designed analog could bind to RXR alpha and modulate its biological activity, including inhibition of the interaction of an N-terminally truncated RXR alpha (tRXR alpha) with the p85 alpha regulatory subunit of phosphatidylinositol-3-OH kinase (PI3K). Here we report the synthesis, testing and SAR of a series of novel analogs of Sulindac as potential modulators for inhibiting tRXR alpha-dependent AKT activation. A new compound 30 was identified to have improved biological activity. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.01.012
• 作为产物：
  描述：

  (E)-3-(4-异丙基苯基)-2-甲基-丙-2-烯酸 在 palladium 10% on activated carbon 、 氢气 作用下， 以 甲醇 为溶剂， 80.0 ℃ 、1.01 MPa 条件下， 反应 36.0h， 生成 6-isopropyl-2-methyl-2,3-dihydro-1H-inden-1-one
  参考文献：
  名称：

  Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation

  摘要：

  RXR alpha represents an intriguing and unique target for pharmacologic interventions. We recently showed that Sulindac and a designed analog could bind to RXR alpha and modulate its biological activity, including inhibition of the interaction of an N-terminally truncated RXR alpha (tRXR alpha) with the p85 alpha regulatory subunit of phosphatidylinositol-3-OH kinase (PI3K). Here we report the synthesis, testing and SAR of a series of novel analogs of Sulindac as potential modulators for inhibiting tRXR alpha-dependent AKT activation. A new compound 30 was identified to have improved biological activity. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.01.012

文献信息

• [EN] CATALYST<br/>[FR] CATALYSEUR
  申请人：BOREALIS AG

  公开号：WO2014096282A1

  公开（公告）日：2014-06-26

  A catalyst in solid particulate form free from an external carrier material comprising (i) a complex of formula (I) wherein M is zirconium or hafnium; each X is a sigma ligand; L is a divalent bridge selected from -R'2C-, -R'2C-CR'2-, -R'2Si-, -R'2Si-Si R'2-, -R'2 Ge-, wherein each R' is independently a hydrogen atom, C1-20-alkyl, tri(C1-20-alkyl)silyl, C6-20-aryl, C7-20-arylalkyl or C7-20-alkylaryl; R2 is a C1-20-hydrocarbyl radical; R2' is a C1-20-hydrocarbyl radical;R6 is a linear or branched aliphatic C1-20-hydrocarbyl group, SR9or OSR9;R6' is a linear or branched aliphatic C1-20-hydrocarbyl group, SR9'or OR9'; with the proviso that neither R6 or R6' represents a group having a quaternary carbon atom directly attached to the indenyl ring; R9 is a C1-20-hydrocarbyl group;R9' is a C1-20-hydrocarbyl group; Ar is a C6-12-aryl or C5-12-heteroaryl group optionally carrying one or more substituents R8; Ar' is a C6-12-aryl or C5-12-heteroaryl group optionally carrying one or more substituents R8';each R8 is a C1-20-hydrocarbyl group;each R8' is a C1-20 -hydrocarbyl group;wherein at least two of R2 and R2'; R6 and R6'; or Ar and Ar' are the same;and (ii) a cocatalyst comprising a compound of a group 13 metal, e.g. Al or boron.

  固体颗粒形式的催化剂，不含外部载体材料，包括（i）公式（I）的配合物，其中M为锆或铪；每个X为σ配体；L为从-R'2C-，-R'2C-CR'2-，-R'2Si-，-R'2Si-SiR'2-，-R'2Ge-中选择的二价桥；其中每个R'独立地是氢原子，C1-20烷基，三(C1-20烷基)硅基，C6-20芳基，C7-20芳基烷基或C7-20烷基芳基；R2为C1-20烃基基团；R2'为C1-20烃基基团；R6为线性或支链脂肪族C1-20烃基团，SR9或OSR9；R6'为线性或支链脂肪族C1-20烃基团，SR9'或OR9'；但R6或R6'均不代表直接连接到茚基环上的季碳原子的基团；R9为C1-20烃基团；R9'为C1-20烃基团；Ar为C6-12芳基或C5-12杂芳基，可选择携带一个或多个取代基R8；Ar'为C6-12芳基或C5-12杂芳基，可选择携带一个或多个取代基R8'；每个R8为C1-20烃基团；每个R8'为C1-20烃基团；其中至少有两个R2和R2'、R6和R6'或Ar和Ar'相同；以及（ii）包括13族金属化合物的共催化剂，例如铝或硼。
• ORGANIC COMPOUNDS
  申请人：Givaudan SA

  公开号：US20200330346A1

  公开（公告）日：2020-10-22

  The present invention refers to indanone derivatives of formula (I) wherein R 1 is selected from hydrogen, methyl and ethyl; R 2 is selected from hydrogen, methyl and ethyl, and R 3 is selected from hydrogen and methyl; or R 2 and R 3 form together with the carbon atoms to which they are attached C 3 -C 5 cycloalkyl; and R 4 is selected from C 2 -C 5 alkyl, C 2 -C 5 alkenyl, C 1 -C 4 alkoxy, C 3 -C 5 cycloalkyl, and C 3 -C 6 cycloalkenyl. The invention further refers to perfume compositions and fragrance applications comprising them.

  本发明涉及式(I)的吲哚酮衍生物，其中R1选择氢、甲基和乙基；R2选择氢、甲基和乙基，R3选择氢和甲基；或R2和R3与它们附着的碳原子一起形成C3-C5环烷基；R4选择C2-C5烷基、C2-C5烯基、C1-C4烷氧基、C3-C5环烷基和C3-C6环烯基。该发明还涉及包含它们的香水组合物和香料应用。
• CATALYST
  申请人：BOREALIS AG

  公开号：US20150329653A1

  公开（公告）日：2015-11-19

  A catalyst in solid particulate form free from an external carrier material comprising (i) a complex of formula (I) wherein M is zirconium or hafnium; each X is a sigma ligand; L is a divalent bridge selected from —R′ 2 C—, —R′ 2 C—CR′ 2 —, —R′ 2 Si—, —R′ 2 Si—SiR′ 2 —, —R′ 2 Ge—, wherein each R′ is independently a hydrogen atom, C 1-20 -alkyl, tri(C 1-20 -alkyl)silyl, C 6-20 -aryl, C 7-20 -arylalkyl or C 7-20 -alkylaryl; R 2 is a C 1-20 -hydrocarbyl radical; R 2′ is a C 1-20 -hydrocarbyl radical; R 6 is a linear or branched aliphatic C 1-20 -hydrocarbyl group, SR 9 or OR 9 ; R 6′ is a linear or branched aliphatic C 1-20 -hydrocarbyl group, SR 9′ or OR 9′ ; with the proviso that neither R 6 or R 6′ represents a group having a quaternary carbon atom directly attached to the indenyl ring; R 9 is a C 1-20 -hydrocarbyl group; R 9′ is a C 1-20 -hydrocarbyl group; Ar is a C 6-12 -aryl or C 5-12 -heteroaryl group optionally carrying one or more substituents R 8 ; Ar′ is a C 6-12 -aryl or C 5-12 -heteroaryl group optionally carrying one or more substituents R 8′ ; each R 8 is a C 1-20 -hydrocarbyl group; each R 8′ is a C 1-20 -hydrocarbyl group; and wherein at least two of R 2 and R 2′ ; R 6 and R 6′ ; or Ar and Ar′ are the same; and (ii) a cocatalyst comprising a compound of a group 13 metal, e.g. Al or boron.

  一种无外部载体材料的固体颗粒形式催化剂，包括(i) 公式（I）的配合物，其中M为锆或铪；每个X为σ配体；L为选择自-R'2C-，-R'2C-CR'2-，-R'2Si-，-R'2Si-SiR'2-，-R'2Ge-的二价桥接基，其中每个R'独立地为氢原子，C1-20烷基，三（C1-20烷基）硅基，C6-20芳基，C7-20芳基烷基或C7-20烷基芳基；R2为C1-20烃基基团；R2'为C1-20烃基基团；R6为线性或支链脂肪族C1-20烃基团，SR9或OR9；R6'为线性或支链脂肪族C1-20烃基团，SR9'或OR9'；但是R6或R6'不代表直接连接到茚烯环上的季碳原子基团；R9为C1-20烃基团；R9'为C1-20烃基团；Ar为C6-12芳基或C5-12杂芳基，可选地携带一个或多个取代基R8；Ar'为C6-12芳基或C5-12杂芳基，可选地携带一个或多个取代基R8'；每个R8为C1-20烃基团；每个R8'为C1-20烃基团；其中至少有两个R2和R2'；R6和R6'；或Ar和Ar'是相同的；以及(ii) 一种辅催化剂，包括13族金属化合物，例如铝或硼。
• PROCESS FOR THE PREPARATION OF A LIGAND FOR A CATALYST
  申请人：Borealis AG

  公开号：EP3301098A1

  公开（公告）日：2018-04-04

  A catalyst in solid particulate form free from an external carrier material comprising (i) a complex of formula (I) wherein M is zirconium or hafnium; each X is a sigma ligand; L is a divalent bridge selected from -R'2C-, -R'2C-CR'2-, -R'2Si-, -R'2Si-SiR'2-,-R'2Ge-, wherein each R' is independently a hydrogen atom, C1-20-alkyl, tri(C1-20-alkyl)silyl, C6-20-aryl, C7-20-arylalkyl or C7-20-alkylaryl; R2 is a C1-20-hydrocarbyl radical; R2' is a C1-20-hydrocarbyl radical; R5 is a linear or branched aliphatic C1-20-hydrocarbyl group, SR9 or OR9; R6' is a linear or branched aliphatic C1-20-hydrocarbyl group, SR9' or OR9'; with the proviso that neither R6 or R6' represents a group having a quaternary carbon atom directly attached to the indenyl ring; R9 is a C1-20-hydrocarbyl group; R9' is a C1-20-hydrocarbyl group; Ar is a C6-12-aryl or C5-12-heteroaryl group optionally carrying one or more substituents R8; Ar' is a C6-12-aryl or C5-12-heteroaryl group optionally carrying one or more substituents R8'; each R8 is a C1-20-hydrocarbyl group; each R8' is a C1-20-hydrocarbyl group; wherein at least two of R2 and R2'; R6 and R6'; or Ar and Ar' are the same; and (ii) a cocatalyst comprising a compound of a group 13 metal, e.g. A1 or boron.

  一种不含外部载体材料的固体颗粒催化剂，包括 (i) 式 (I) 复合物 其中 M 是锆或铪 每个 X 是σ配体； L 是选自-R'2C-、-R'2C-CR'2-、-R'2Si-、-R'2Si-SiR'2-、-R'2Ge-的二价桥，其中每个 R'独立地为氢原子、C1-20-烷基、三(C1-20-烷基)硅基、C6-20-芳基、C7-20-芳基烷基或 C7-20- 烷基芳基； R2 是 C1-20- 烃基； R2' 是 C1-20-氢羰基； R5 是直链或支链脂肪族 C1-20- 氢羰基、SR9 或 OR9； R6'是直链或支链脂肪族 C1-20-氢羰基、SR9'或 OR9'； 但 R6 或 R6'均不代表具有直接连接到茚基环的季碳原子的基团； R9 是 C1-20 碳氢基团； R9' 是 C1-20- 氢化羰基； Ar 是 C6-12- 芳基或 C5-12- 异芳基，可选择带有一个或多个取代基 R8； Ar' 是 C6-12- 芳基或 C5-12- 异芳基，可选择带有一个或多个取代基 R8'； 每个 R8 均为 C1-20- 氢化羰基 每个 R8'是一个 C1-20-氢羰基； 其中至少两个 R2 和 R2'；R6 和 R6'；或 Ar 和 Ar'是相同的； 和(ii)由第 13 族金属，例如 A1 或硼的化合物组成的助催化剂。
• Organic compounds
  申请人：Givaudan SA

  公开号：US11020333B2

  公开（公告）日：2021-06-01

  The present invention refers to indanone derivatives of formula (I) wherein R1 is selected from hydrogen, methyl and ethyl; R2 is selected from hydrogen, methyl and ethyl, and R is selected from hydrogen and methyl; or R2 and R3 form together with the carbon atoms to which they are attached C3-C5 cycloalkyl; and R4 is selected from C2-C5 alkyl, C2-C5 alkenyl, C1-C4 alkoxy, C3-C5 cycloalkyl, and C3-C6 cycloalkenyl. The invention further refers to perfume compositions and fragrance applications comprising them.

  本发明涉及式 (I) 的茚酮衍生物 在其中 R1 选自氢、甲基和乙基 R2 选自氢、甲基和乙基，R 选自氢和甲基；或 R2 和 R3 与它们所连接的碳原子一起形成 C3-C5 环烷基；以及 R4 选自 C2-C5 烷基、C2-C5 烯基、C1-C4 烷氧基、C3-C5 环烷基和 C3-C6 环烯基。 本发明还涉及香水组合物和包含它们的香料应用。